← All organizations

Resverlogix Corp

For profitWebsite ↗

Also known as: Resverlogix Corp

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 30, 2024

Timeline

2000s

Jun 1, 2000
Resverlogix Corp— Founded

Drugs by trial phase (3 distinct, 12 trials)

Phase 3 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (14)

NCT06590324OfficialPhase 2/Phase 3Nov 30, 2024
NCT06590324Lead sponsorPhase 2/Phase 3Nov 30, 2024
NCT04915300CollaboratorPhase 2Dec 31, 2021
NCT04894266Lead sponsorPhase 2/Phase 3Nov 1, 2021
NCT03228940Lead sponsorPhase 1/Phase 2Jan 31, 2019
NCT03160430Lead sponsorPhase 1/Phase 2Jun 15, 2017
NCT02586155Lead sponsorPhase 3Oct 1, 2015
NCT01863225Lead sponsorPhase 2May 1, 2013
NCT01728467Lead sponsorPhase 2Nov 1, 2012
NCT01067820Lead sponsorPhase 2Sep 1, 2011
NCT01423188Lead sponsorPhase 2Aug 1, 2011
NCT01058018Lead sponsorPhase 2Dec 1, 2009
NCT00768274Lead sponsorPhase 1/Phase 2Sep 1, 2008
NCT00768274Study directorPhase 1/Phase 2Sep 1, 2008

Details

Founded: Calgary, AB, CA Jun 1, 2000
Last known activity: Nov 30, 2024